Background. Early identification of sepsis is important to be able to initiate timely therapy and optimize survival. Neutrophil CD64 (nCD64) expression has been proposed as a potential marker of sepsis.
Sepsis, the host response to infection, remains an important cause of mortality in acutely ill patients [1] . Early identification and prompt and appropriate treatment of sepsis can have a major impact on the outcome of septic patients [2, 3] and prevent unnecessary, potentially harmful, and costly therapeutic interventions for patients who do not have sepsis. However, sepsis can be difficult to identify. CD64, the high-affinity immunoglobulin Fc γ receptor I, is constitutively expressed on monocytes and, to a very low extent, on resting neutrophils. Interestingly, CD64 expression on neutrophils increases once these become activated by the proinflammatory cytokines interferon gamma (IFN-γ) and granulocyte colony-stimulating factor (G-CSF), produced in response to infection or after exposure to endotoxin [4, 5] . Several studies have indicated that neutrophil CD64 (nCD64) is a highly sensitive and specific marker for systemic infection and sepsis in adults, neonates, and children [6, 7] . However, studies evaluating nCD64 expression in the critical care setting have varied in methodology and reported conflicting results [8] [9] [10] [11] . Additionally, none of these studies examined the role of nCD64 expression in monitoring the response to sepsis treatment or in diagnosing intensive care unit (ICU)-acquired infections, and did not evaluate nCD64 expression in combination with the widely used sepsis marker C-reactive protein (CRP).
Accordingly, we conducted a prospective study in a large, unselected population of critically ill patients, to evaluate, in everyday practice, the utility of nCD64 expression for identification of sepsis at admission and during the ICU stay and for monitoring the clinical course of sepsis.
PATIENTS AND METHODS
This prospective, observational study was conducted in the 34-bed medico-surgical Department of Intensive Care at Erasme University Hospital, an 850-bed academic center. The study was approved by the institution's ethics committee (reference number P2010/193). Informed consent was waived because no additional blood sampling was needed and routine patient care was not modified.
All consecutive adult patients aged ≥18 years admitted to the ICU for >4 hours during a 3.5-month period (16 August through 30 November 2010) were prospectively enrolled. Exclusion criteria were lack of nCD64 measurement and administration of recombinant G-CSF or IFN-γ during the month before ICU admission. If a patient was readmitted during the study period, he/she was included as a new case.
Demographic, clinical, biochemical, and microbiological data were collected throughout the ICU stay. The Acute Physiology and Chronic Health Evaluation (APACHE) II score [12] was calculated at admission and the Sequential Organ Failure Assessment (SOFA) score [13] at admission and daily thereafter. Microbiological sampling was performed at the discretion of the treating physicians. Routine surveillance cultures (of tracheal aspirate or sputum, urine, nasal and anal swabs, drainage systems, and wounds) were taken at admission and twice weekly. 
Neutrophil CD64 Measurement
Residual blood (20 μL) from the routine sample drawn for complete blood count with leukocyte differential was used for nCD64 determinations by flow cytometry (FC500 Beckman Coulter, Miami, Florida) within 4 hours after collection. Full details of this technique are provided in the Supplementary Data. Values of nCD64 are expressed as median fluorescence intensity (MFI).
Definitions
Diagnoses of sepsis, severe sepsis, septic shock, and site-specific infections were made according to consensus definitions [14, 15], taking into account microbiology data, imaging studies, surgical and biopsy findings, necropsy reports, response to antibiotics, and outcome. The attending physicians and investigators who established the diagnosis, including in all cases a senior intensivist, were blinded to nCD64 results, but received CRP results as usual. The choice, dose, route, duration, and combination of antibiotic treatments were decided on and reviewed jointly with an infectious disease specialist. The laboratory personnel who performed and analyzed the flow cytometry data were blinded to any information regarding the patients. Sepsis at admission was defined as sepsis present within 48 hours of ICU admission. ICU-acquired infection was defined as infection identified >48 hours after ICU admission. First-line empirical antibiotic treatment was considered to be appropriate if all pathogenic microorganisms were susceptible in vitro to at least 1 antibiotic administered, as determined by the sensitivity pattern. Antibiotic treatment was regarded as inadequate/inappropriate when antibiotic treatment was administered with a delay of >24 hours, when antibiotic therapy did not cover all organisms in polymicrobial sepsis, or when microbes were resistant or had intermediate sensitivity. For culture-negative sepsis, antibiotic treatment was deemed appropriate if it was consistent with the local empiric antibiotic protocol. Candida species isolated from the lung were considered colonizers unless also present at multiple other sites. Staphylococcus non-aureus isolated in blood cultures was not considered a pathogen, unless multiple samples grew the same species with the same antibiotic resistance pattern.
Statistical Analysis
Continuous variables are presented as median and lower and upper quartiles and categorical variables as number and percentage, unless otherwise specified. Groups were compared by χ 2 test, Fisher exact test, or Mann-Whitney U test, as appropriate. For repeated measures, a linear mixed-models procedure with restricted maximum likelihood estimation and with an unstructured covariance structure was used to test for the effects of time as the repeated factor treated as categorical, with group and group × time interactions included in the considered models. A Bonferroni correction was used in post hoc comparisons.
Receiver operating characteristic (ROC) curves with areas under the curve (AUC) were constructed to represent the spectrum of sensitivity/specificity values at all possible cutoff values. The Youden index was used to identify the cutoff points. Values for sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive and negative likelihood ratios, and odds ratios (ORs) with their 95% confidence intervals (CIs) were calculated using a 2 × 2 table. The Pearson correlation coefficient was calculated to quantify the association between nCD64 expression and CRP or white blood cell (WBC) count. 6.9 (4.9-9.6) Abbreviations: AUC, area under the curve; CI, confidence interval; CRP, C-reactive protein; LR+, likelihood ratio for positive test; LR-, likelihood ratio for negative test; nCD64, neutrophil CD64; NPV, negative predictive value; PPV, positive predictive value; Se, sensitivity; Sp, specificity.
Multiple logistic regression was used to identify the variables independently associated with a diagnosis of sepsis or with the appropriateness of empirical antibiotic treatment. Variables with a P < .05 in univariate analysis were entered into the multivariable logistic regression model. The predictors included demographic and clinical parameters, as well as nCD64 and CRP measurements. Continuous predictors were transformed into dichotomous variables, using the cutoffs indicated by ROC curve for nCD64 expression and CRP and the population median for the other variables. Interaction terms were also tested. Multiple regression analysis was performed using the "backward likelihood ratio" method. Cumulative incidence curves for ICU-acquired infection were drawn and compared using a log-rank test. We also performed a Cox regression analysis to examine factors associated with development of ICU-acquired infection. The length of stay until ICU-acquired infection was considered as the time until event and the length of stay until death, if it occurred before infection, or discharge was considered as the censored time. Variables that were considered in the analysis were dichotomized APACHE II, need for mechanical ventilation before the event, and dichotomized maximum variation of nCD64 (MaxVarCD64, defined as the maximum of the differences between each 2 consecutive nCD64 measurements for the period before the occurrence of the event or censored time). All significance tests were 2-sided and a P value <.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics 19.
RESULTS
Of a total of 722 adult patients admitted for >4 hours during the observation period, 548 cases with at least 1 nCD64 measurement were included in the study; 40 of these were readmissions ( Figure 1 ).
Neutrophil CD64 Expression at Admission
Neutrophil CD64 expression was measured within 24 hours of admission in 468 patients. Their baseline characteristics are shown in Table 1 and Supplementary Table 1 . Among these 468 patients, 103 (22%) had sepsis, of whom 34 (33%) had septic shock (Supplementary Table 2) .
At ICU admission, nCD64 expression and CRP concentration were significantly higher in septic compared to nonseptic patients, whereas the WBC count did not differ significantly (Table 1 ROC curve analysis of nCD64 expression for identifying sepsis at admission showed an AUC of 0.94 (95% CI, .92-.97; P < .001). An nCD64 expression of 230 MFI was the best cutoff for identifying sepsis at admission, resulting in a sensitivity of 89% (95% CI, 81%-94%), specificity 87% (95% CI, 83%-90%), PPV 66% (95% CI, 57%-73%), and NPV 97% (95% CI, 94%-98%) ( Table 2) . At a cutoff of 230 MFI, the sensitivity of nCD64 was 100% in patients with gram-positive infections, 90% in patients with gram-negative infections, 93% in culturepositive patients, and 78% in culture-negative patients. Multivariable analysis showed that nCD64 expression ≥230 MFI was significantly and independently associated with a diagnosis of sepsis, with an OR of 55 (95% CI, 27-111) and adjusted OR of 40 (95% CI, 15-103) (P < .001; Supplementary Table 3) .
The diagnostic accuracy of nCD64 expression as assessed by AUC was consistent across various clinical subgroups, including patients with leukopenia (n = 16, AUC = 0.95), immunosuppression (n = 81, AUC = 0.93), chronic renal failure (n = 23, Figure 2 . Additive value of neutrophil CD64 (nCD64). Differential likelihood ratios for sepsis diagnosis after adding nCD64 expression to C-reactive protein measurement at intensive care unit admission. Abbreviations: CRP, C-reactive protein; LR, likelihood ratio; MFI, median fluorescence intensity; nCD64, neutrophil CD64; NS, nonseptic; S, septic. There was a significant correlation between nCD64 expression and CRP concentration (r = 0.56, P < .001) but not between nCD64 expression and WBC (r = 0.057, P = .22) or neutrophil count (r = 0.048, P = .404). In 451 patients who had both nCD64 expression and CRP results available concurrently (Table 2) , the results of both were abnormal (nCD64 ≥230 MFI and CRP ≥3.5 mg/dL) in 85 (19%), 78 of whom had sepsis ( Figure 2) ; thus, a double "positive" result was associated with a 92% probability of having sepsis (PPV) and an NPV of 93%. The sensitivity of CRP + nCD64 was reduced (76%) compared to that of nCD64 alone, but specificity increased to 98% and the error rate decreased significantly from 14.2% (CRP alone) to 6.9% (P < .001). Of the 265 patients (59% of our cohort) who had normal results for both tests, 262 did not have sepsis; hence, a double "negative" result ruled out sepsis with a probability of 99%. 
AUC =
0.94), liver cirrhosis (n = 22, AUC = 0.89), after solid organ transplant (n = 21, AUC = 0.96), and those who received steroids (
Serial nCD64 Determinations in Septic Patients
Of the 130 patients with sepsis at admission (Table 3) , 44 (34%) received inappropriate empirical antibiotic treatment, mainly because of the presence of gram-negative bacteria resistant to the antibiotics administered (43%).
Patients who received inappropriate empirical antibiotic treatment had persistently elevated nCD64 expression over time ( Figure 3) . Patients who received appropriate antibiotics had reduced nCD64 expression at day 4 and thereafter compared to admission values. An nCD64 expression >260 MFI at day 3, the best cutoff by ROC curve analysis, identified inappropriate antibiotic treatment with a sensitivity of 93% (95% CI, 66%-100%) and specificity of 48% (95% CI, 30%-67%) (Supplementary Table 4 ). Multivariable analysis showed that nCD64 expression ≥260 MFI at day 3 was significantly and independently associated with inappropriate antibiotic treatment, with an OR of 13 (95% CI, 1-112) and adjusted OR of 10 (95% CI, 1-94) (P = .039; Supplementary Table 5) .
Serial nCD64 Determinations in Nonseptic Patients
Twenty-nine (6.9%) of the 418 patients without sepsis at admission developed sepsis during their ICU stay (Table 4, Supplementary Table 6 , and Supplementary Figure 1) . Patients who developed an infection showed an increase in nCD64 expression between 2 consecutive measurements (MaxVarCD64) before the diagnosis of infection, which was significantly higher than any increase in nCD64 expression in patients without infection (88 and 21, respectively; P < .001). ROC curve analysis established that 40 was the best cutoff to identify ICU-acquired infection, with a sensitivity of 88% (95% CI, 69%-97%) and specificity of 65% (95% CI, 58%-72%) (Supplementary Table 7 ). Patients with MaxVarCD64 ≥40 MFI had a greater probability of developing ICU-acquired infection compared to patients with MaxVarCD64 <40 MFI, according to cumulative incidence curves (P < .001, Figure 4 ). Cox regression analysis showed that an increase in nCD64 expression ≥40 MFI was significantly and independently associated with ICU-acquired infection, with an adjusted hazard ratio of 6.2 (95% CI, 1.8-20.8; P = .003; Supplementary Table 8) .
DISCUSSION
The present study, assessing the performance of nCD64 expression, included a larger adult population than in previously published studies. The heterogeneous cohort of patients, including medical, surgical, and trauma patients, reflects the real-life clinical spectrum of patients in which nCD64 expression could potentially be applied.
We observed that nCD64 expression had a sensitivity of 89% and specificity of 87% for diagnosing sepsis at admission, suggesting that nCD64 is a useful diagnostic marker. These results are in line with previous studies in adult critically ill patients [8, 9, 11] . In a study by Cardelli et al [8] , nCD64 expression had 96% sensitivity and 95% specificity (AUC = 0.97) for detecting bacteremia among 112 patients selected using systemic inflammatory response syndrome (SIRS) criteria. Hsu et al [9] reported that nCD64 expression discriminated severe sepsis or septic shock from SIRS with 89% sensitivity and 96% specificity (AUC = 0.93) in 66 patients with respiratory failure. In a more recent study by Gibot et al [11] , nCD64 expression had 84% Figure 3 . Time course of neutrophil CD64 expression in patients with sepsis at admission according to empirical antibiotic treatment: appropriate (black) or inappropriate (gray). Data are presented as means with 95% confidence intervals. The numbers of patients with available data at each time point are shown at the bottom of the graph. Data are analyzed using a mixed models procedure and P values were corrected taking into account multiple comparisons. *P < .05 for the comparison between appropriate and inappropriate treatment group for the day indicated. † P < .05 for the comparison within inappropriate treatment group between the day indicated and day 0. # P < .05 for the comparison within appropriate treatment group between the day indicated and day 0. Abbreviations: MFI, median fluorescence intensity; nCD64, neutrophil CD64. sensitivity and 95% specificity (AUC = 0.97) to identify sepsis among 300 critically ill patients. These results, and ours, contrast with the lower AUC (0.80) and sensitivity of nCD64 expression (63%) recently reported by Gros et al [10] , although the reported specificity was high (89%). The inclusion of only patients with microbiologically confirmed infection in the infected group, leading to a higher cutoff, and of patients with viral or fungal infections, who are expected to have raised nCD64 expression [16, 17] , in the control group, may have led to an underestimation of the discriminatory power of nCD64 in this study [10] . The diagnostic accuracy of nCD64 expression may be better for discriminating septic from nonseptic patients [9, 11] than for discriminating bacterial from nonbacterial infection [10] . In line with several previous studies [10, 16, 18, 19] , nCD64 expression was not significantly different in grampositive and gram-negative bacterial infections. In agreement with previous reports [9, 10, 20] , nCD64 was weakly associated with severity of sepsis and patient prognosis.
The diagnostic utility of nCD64 expression was valid across several major clinical subgroups, including patients who were immunosuppressed and those with chronic renal failure or liver cirrhosis. In neutropenic patients, neutrophils can still upregulate the expression of nCD64 on activation, so this measure has diagnostic utility in neutropenia. Similarly, nCD64 kept its discriminative value in patients pretreated with systemic corticosteroids.
The lack of correlation between nCD64 and WBC and the weak, although significant, correlation between nCD64 and Data are presented as median (lower-upper quartile) unless otherwise specified.
Abbreviations: APACHE II, Acute Physiologic and Chronic Health Evaluation II; CRP, C-reactive protein; ICU, intensive care unit; LOS, length of stay; MaxVarCD64, the maximum difference between 2 consecutive nCD64 measurements before the day of event; MFI, median fluorescence intensity; nCD64, neutrophil CD64; SOFA, Sequential Organ Failure Assessment; WBC, white blood cell. a Event was defined as the day of isolation of microbes or initiation of antibiotics, whichever came first, for patients with ICU-acquired infection, and the day of ICU discharge or death for patients without ICU-acquired infection.
CRP, as found in other studies [5, 19, 21] , suggest that nCD64 is not a surrogate for these commonly used markers of infection. nCD64 may rather reflect different pathophysiological aspects of sepsis. Interestingly, nCD64 was independently associated with the diagnosis of sepsis in multiple logistic regression analysis, suggesting that additional information is provided by measurement of nCD64 expression. The reported diagnostic accuracy of CRP in our study, as assessed by AUC, sensitivity, and specificity, was higher than in previous studies [22] . It is possible that these results were influenced by the fact that attending clinicians were not blinded to CRP measurements and CRP is widely used and incorporated in routine diagnostic algorithms for infection and sepsis. Addition of nCD64 expression can enhance the diagnostic accuracy of CRP to identify sepsis. In our cohort, CRP correctly classified 86% of patients as having sepsis or not, and this percentage further increased to 93% when nCD64 was added. Fischer et al [23] reported that an initially increased nCD64 expression decreased within the first days of septic shock. However, our study is the first to address the time course of nCD64 in relation to the appropriateness of antibiotic treatment. Septic patients with nCD64 expression ≥260 MFI at day 3 had a 13-fold increased odds of having received inappropriate antibiotic treatment. Conversely, septic patients with nCD64 values <260 MFI at day 3 had a 94% probability of having received appropriate antibiotics. The specificity and PPV for these analyses were quite low; nevertheless, at 3 days after ICU admission, although the type of pathogen may have been identified, sensitivity patterns may not yet be available so that this information could be of use, and even more so when no pathogen is isolated (in 25% of our cohort).
To our knowledge, the present study is the only one to evaluate the role of nCD64 expression in the identification of ICUacquired infection. Grey et al [24] showed that nCD64 expression increased in patients with infectious complications following solid organ transplant. We found that serial measurements of nCD64 in nonseptic patients could predict ICU-acquired infection, although with lower diagnostic accuracy than for the diagnosis of sepsis at admission.
Our study has several limitations. First, the prevalence of sepsis at admission was lower than in other studies, thus inflating the NPV but decreasing the PPV. Second, the present investigation was a single-center study, limiting the generalizability of our data to settings with different case mixes. Third, nCD64 expression was measured only when trained laboratory personnel were on duty and, therefore, not obtained during the night or weekend, which may have introduced some selection bias. Fourth, sepsis is not a single disease entity but a syndrome characterized by a high degree of heterogeneity. Despite the fact that investigators made meticulous efforts to minimize misclassification by using post hoc diagnosis, misclassifications may have occurred.
At present, implementation of nCD64 in everyday practice is limited by the lack of standardized flow cytometry protocols across different laboratories, the cost, and limited access to round-the-clock flow cytometric facilities. A new platform, HematoFlow, which combines a hematology analyzer with a flow cytometer, can measure the WBC differential but also nCD64 expression. This type of platform should make cytometric results more readily available. It should be noted that measurement of the MFI of nCD64 does not allow comparison across different laboratories [25] , in contrast to the CD64 index measured using the Leuko64 assay kit and reported in some other studies [7, 10, 11] . The increased costs of this commercial kit are, however, likely not justified over manually determined MFI for use in a single flow cytometer, because a study comparing the 2 methods reported equal diagnostic accuracy [26] .
In conclusion, our study demonstrates the utility of routine daily determinations of nCD64 expression as a monitoring tool in the ICU. In centers that use CRP routinely, addition of daily measurement of nCD64 expression could facilitate sepsis diagnosis. Daily monitoring of nCD64 expression in critically ill patients may help in the diagnosis of ICU-acquired infection and in assessing the appropriateness of antibiotic therapy. The results of our study need to be validated in multicenter studies using standardized analytical methodology.
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Supplementary materials are available at Clinical Infectious Diseases online (http://cid.oxfordjournals.org/). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the Figure 4 . Cumulative incidence curves for intensive care unit-acquired infection for patients with maximum variation of neutrophil CD64 before the event (MaxVarCD64) ≥40 median fluorescence intensity (MFI; black line) and for patients with MaxVarCD64 <40 MFI (gray line), compared using a log-rank test. Abbreviations: MFI, median fluorescence intensity; nCD64, neutrophil CD64.
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